中山那治疗痔疮好点中山华都肛肠医院怎么网上预约好不好,中山大便出血时怎么回事,中山便秘的解决办法,中山便血应该怎么办呢,中山大便中有血是怎么回事,中山大便拉出血是什么病,中山哪家肛瘘医院好

BEIJING, Feb. 20 (Xinhua) -- Chinese Vice Premier Wang Qishan on Sunday called for sound and fast development of the nation's tourism industry as he called it a strategic pillar of the national economy.The tourism industry has huge potential, which needs further opening up, reform and innovation. Market should play a fundamental role in allocating the resources, Wang told a meeting of tourism work.He stressed the diversified needs of customers should be met, and the market order should be standardized to protect customer's legitimate rights."Local authorities should work together to make tourism a strategic pillar industry," he said.Wang also noted tour guide forces play a very important role in the industry development.More training should be arranged in the areas of professional skills and ethics, as well as response to emergencies.The wage and social security system of the work force should also be improved, he said.

SEOUL, April 12 (Xinhua) -- South Korea has downgraded its alert level for foot-and-mouth disease (FMD) one notch as the disease has practically come to an end, the Ministry for Food, Agriculture, Forestry and Fisheries said Tuesday.The ministry said that it lowered the alert level from "orange" to "yellow," the second-lowest status in the four-tiered alert system, as no additional burial of livestock has occurred in three weeks after the last case in Hongseong, South Chungcheong Province, on March 21.The country dropped the alert level from the highest level of " red" to "orange" on March 24.The highly contagious animal disease, first confirmed on Nov. 29, has forced the country to cull more than 3.47 million livestock, mostly pigs and cattle, resulting in losses of 3 trillion won (2.6 billion U.S. dollars).The ministry, meanwhile, said that 670 animal quarantine experts will continue to decontaminate livestock farms once every week and keep close watch to see if any animals become sick.

COPENHAGEN, April 30 (Xinhua) -- As traditional Chinese medicine (known as TCM in Europe) becomes increasingly popular worldwide and has gradually been regarded as a useful component to Western medical treatments, Denmark is no stranger to such trends.According to a study published by the University of Copenhagen in mid-Feb., up to one-third of Danish hospitals choose complementary or alternative therapies, including TCM methods, to treat pain, cancer, mental disease, tumors and infertility. Acupuncture remains the most widely-practiced form of these treatments, used in some 97 percent of the cases.The nationwide acceptance of acupuncture and massage therapists, the growing ranks of herbal practitioners, and the hosting of an annual pan-Scandinavian TCM conference since 2007, all underline the popularity of alternative medicine, including the TCM, in the country.However, the overall market presence of TCM, and herbal medicines in particular, is relatively small in Denmark and Europe at large. As many European policymakers insist that traditional herbal medicines "are neither scientifically documented nor tested according to Western requirements," these treatments face difficulties in obtaining licenses and boosting sales in Europe.In fact, despite their historical pedigree and widely-accepted efficacy, TCM products are often classified as "healthcare products" or "food," rather than "drugs" in European markets.A big challenge for TCM products to gain more access to the continent is the EU's Traditional Herbal Medicinal Products Directive, which stipulates that all such products must obtain authorization if they are to be sold within the EU, starting May 1, 2011.The directive says producers must prove the product in question has been used for 30 years, 15 of which within the EU, so as to ensure its safety.While licensing is expected to be onerous and expensive, Denmark has tried to bring TCM products into the Western medical mainstream from as early as 2005. The country's well-developed biochemical and medical industry, modernized agriculture and horticulture sectors and a strong track record of cooperative research in these fields, has helped TCM's cause.For instance, Traditional Complementary Medicine Denmark, a company helping herbal product makers market their goods in Western countries, uses modern biotechnology processes and clinical trials to scientifically verify and document the efficacy of existing herbal medicines.It also advises herbal product makers on how to align their standards with European requirements so as to acquire the necessary sales licenses. Sometimes, simple solutions like clearer and more detailed labeling of a TCM product's ingredients can help improve its marketability. Patent applications and drug approvals procedures must follow, before the product can access the EU pharmaceutical market, usually in pill form.Investing in herbal medicine also makes financial sense for Denmark, as it is encourages development of low-bulk, high-value agricultural products, which can be easily transported all over the globe.Development Centre Aarslev, a Danish agro-research body and partner of TCM Denmark, studies the active ingredients contained in medicinal plants and their impact on human health conditions such as cardiovascular problems, diabetes and allergies. One of the earliest collaborations it undertook with a producer of herbal medicine showed the effectiveness of extracts from the hips of the dog rose plant in treating rheumatoid arthritis.A spokesperson for the institution said, "We have documented analytical evidence which shows that arthritis patients can reduce their consumption of conventional anti-arthritis drugs by up to 50 percent, if they combine them with the herbal drug based on dog rose hips."Given Denmark's population of 5.5 million people, this could translate into savings of 200 million U.S. dollars a year on anti-arthritis medication, the spokesperson added.Other plant-based interventions could hold wider public health benefits. TCM practitioners say herbal medicines can improve blood circulation in humans, and contain naturally-occurring antioxidants which can reduce the risks of heart attacks and better regulate cardiovascular functions. This has potentially wide-ranging benefit for Western societies, where heart disease is a major threat.Heart disease was the most common cause of death in Denmark until 2000, and cardiovascular disease the commonest until 2008, with cancer now ranking the biggest killer.In fact, TCM herbal remedies are also considered a good choice for cancer treatment, as certain plants contain hormone-like substance which can influence hormone-dependent cancers, such as breast and prostate cancer.TCM supporters say the obvious benefit of such an intervention is the avoidance of more commonly-used chemotherapy and radiation treatments which often produce severe side-effects in patients. Relevant herbal therapies can help strengthen cancer patient's immune system, reduce side-effects of chemotherapy and radiation therapy, and alleviate other symptoms of the disease.Given the many potential benefits of TCM, the EU's tightening of rules may appear harsh. Still, TCM is considered a relatively novel approach to medicine in Europe. Moreover, the dominant market share and general clout of the chemical-based, Western pharmaceutical industry also makes it difficult for traditional remedies to stake their claim.

JOHANNESBURG, March 23 (Xinhua) -- Cervical cancer ranks as the second most frequent cancer among women in South Africa.Recent information from a World Health Organization (WHO) and ICO Information Center on Human Papilloma virus (HPV) and Cervical Cancer 2010 report shows that 16.84 million South African women aged 15 years and older are at risk of developing cervical cancer.Current estimates indicate that every year 5,743 women are diagnosed with cervical cancer and more than 3,000 die from the disease.About 21 percent of women in the general South African population are estimated to harbor cervical HPV infection at any given time, and 62.8 percent of invasive cervical cancers are attributed to HPV subtypes 16 or 18."Concern is growing as there appears to be an increasing epidemic of papillomavirus-induced disease involving not only the cervix but elsewhere in the female genital tract and anogenital region," said Professor Martin Hale, head of the Department of Anatomical Pathology at the University of the Witwatersrand (Wits) in Johannesburg and the National Health Laboratory Service.The South African population and people from Africa in general have high incidences of the HPV subtypes 16 or 18 according to Professor Hale. He is not entirely sure why but is of the opinion that the infection rate can be lowered."The common theory is that HPV is transmitted through sexual intercourse. If treated like a sexual disease and the necessary precautions are taken during sex the infection rate can be lowered, " Hale told Xinhua in an interview on Wednesday.HPV is also exacerbated as a result of the HIV pandemic and cause a rapid progression of premalignant dysplasia to invasive cancer in HIV positive patients.Hale believes the limited access to information and resources make it easy for the condition to thrive.However, according to Hale, a debate is still raging on how, to whom and whether the vaccine should be administered.Black women are at higher risk of contracting HPV and subsequent cervical cancer. Other risk factors that increase susceptibility include age of first intercourse, the number of children per woman, and a weakened immune system, to name a few."To avoid getting cervical cancer get the vaccine against HPV 16 and 18 infection before starting to be sexually active, have protected sex and go for regular screenings," he told Xinhua.

LOS ANGELES, May 5 (Xinhua) -- NASA has selected three planetary missions from which it will pick one potential mission to look at Mars' interior for the first time, NASA's Jet Propulsion Laboratory (JPL) announced on Thursday.The Mars mission, to be launched in 2016, would be led by JPL, according to the announcement.The other two missions would study an extraterrestrial sea on one of Saturn's moons; or study in unprecedented detail the surface of a comet's nucleus, said JPL in Pasadena, Los Angeles.The selected investigations could reveal much about the formation of our solar system and its dynamic processes, JPL said.Each mission will receive three million dollars to conduct its mission's concept phase or preliminary design studies and analyses, JPL said in a news release.After another detailed review in 2012 of the concept studies, NASA will select one to continue development efforts leading up to launch. The selected mission will be cost-capped at 425 million dollars, not including launch vehicle funding, according to JPL.NASA's Discovery Program requested proposals for spaceflight investigations in June 2010. A panel of NASA and other scientists and engineers reviewed 28 submissions."NASA continues to do extraordinary science that is re-writing textbooks," said NASA Administrator Charles Bolden. "Missions like these hold great promise to vastly increase our knowledge, extend our reach into the solar system and inspire future generations of explorers."